Paradoxical effect of 1-(1-naphthylmethyl)-piperazine on resistance to tetracyclines in multidrug-resistant Acinetobacter baumannii

Journal of Antimicrobial Chemotherapy

Volumn 63, Issue 2, 2009, Pages 349-352

  Bean, D C ^a   Wareham, D W ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

Acinetobacter; Efflux inhibitor; Tigecycline

Indexed keywords

1 (1 NAPHTHYLMETHYL)PIPERAZINE; DOXYCYCLINE; MINOCYCLINE; PIPERAZINE DERIVATIVE; TETRACYCLINE; TIGECYCLINE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; DISK DIFFUSION; DRUG ANTAGONISM; DRUG POTENTIATION; GROWTH INHIBITION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; POLYMERASE CHAIN REACTION;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; DRUG INTERACTIONS; ENZYME INHIBITORS; GREAT BRITAIN; HUMANS; MICROBIAL SENSITIVITY TESTS; PIPERAZINES; TETRACYCLINE RESISTANCE; TETRACYCLINES;

EID: 58849163598     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn493     Document Type: Article

References (10)

1. Doan TL, Fung HB, Mehta D et al. Tigecycline: A glycylcycline antimicrobial agent. Clin Ther 2006; 28: 1079-106.
2. Peleg AY, Potoski BA, Rea R et al. Acinetobacter baumannii bloodstream infection while receiving tigecycline: A cautionary report. J Antimicrob Chemother 2007; 59: 128-31.
3. Navon-Venezia S, Leavitt A, Carmeli Y. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother 2007; 59: 772-4.
4. Peleg AY, Adams J, Paterson DL. Tigecycline efflux as a mechanism for non-susceptibility in Acinetobacter baumannii. Antimicrob Agents Chemother 2007; 51: 2065-9.
5. Ruzin A, Keeney D, Bradford PA. AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex. J Antimicrob Chemother 2007; 59: 1001-4.
6. Magnet S, Courvalin P, Lambert T. Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob Agents Chemother 2001; 45: 3375-80.
7. Pannek S, Higgins PG, Steinke P et al. Multidrug efflux inhibition in Acinetobacter baumannii: Comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-{β}-naphthylamide. J Antimicrob Chemother 2006; 57: 970-4.
8. Andrews JM. BSAC standardized disc susceptibility testing method (version 7). J Antimicrob Chemother 2008; 62: 256-78.
9. Woodford N, Ellington MJ, Coelho JM et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006; 27: 351-3.
10. Coelho JM, Turton JF, Kaufmann ME et al. Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. J Clin Microbiol 2006; 44: 3623-7.